Vimian Group
29.96 SEK
-0.93 %
Less than 1K followers
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.93 %
+0.54 %
-3.23 %
-29.84 %
-24.72 %
-28.92 %
-6.63 %
-
-61.75 %
Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.
Read moreMarket cap
15.84B SEK
Turnover
3.12M SEK
Revenue
4.3B
EBIT %
13.13 %
P/E
65.3
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
29.4
2026
Interim report Q1'26
29.4
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO
Vimian has resolved to issue and repurchase class D shares, class E1 2025 shares, class E2 2025 shares, and class E3 2025 shares as part of its long-term incentive program 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
